Outset Medical Inc Asset Resilience Ratio
Outset Medical Inc asset resilience ratio. Outset Medical Inc (OM) has an Asset Resilience Ratio of 46.29% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Outset Medical Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Outset Medical Inc (2018–2025)
Asset resilience ratio of Outset Medical Inc from 2018 to 2025. This chart shows how Outset Medical Inc's Asset Resilience Ratio has changed over time. Read total liabilities of Outset Medical Inc for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Outset Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Outset Medical Inc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $112.19 Million | 46.29% |
| Total Liquid Assets | $112.19 Million | 46.29% |
Asset Resilience Insights
- Very High Liquidity: Outset Medical Inc maintains exceptional liquid asset reserves at 46.29% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Outset Medical Inc Industry Peers by Asset Resilience Ratio
Compare Outset Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Outset Medical Inc Asset Resilience Ratio by Year (2018–2025)
Outset Medical Inc asset resilience ratio by year from 2018 to 2025. The table below shows the annual Asset Resilience Ratio data for Outset Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 50.64% | $133.94 Million | $264.50 Million | +38.07pp |
| 2024-12-31 | 12.57% | $34.67 Million | $275.80 Million | -30.39pp |
| 2023-12-31 | 42.96% | $134.81 Million | $313.80 Million | -10.59pp |
| 2022-12-31 | 53.55% | $214.28 Million | $400.12 Million | +19.65pp |
| 2021-12-31 | 33.91% | $157.14 Million | $463.46 Million | +28.98pp |
| 2020-12-31 | 4.93% | $19.90 Million | $403.83 Million | -32.59pp |
| 2019-12-31 | 37.52% | $33.15 Million | $88.37 Million | -34.95pp |
| 2018-12-31 | 72.47% | $109.52 Million | $151.13 Million | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more